Show simple item record

Letter To The Editor: Subcutaneous (Sc) Methotrexate (Mtx) Is Better And Well-Tolerable Than Oral Mtx In Rheumatoid Arthritis Patients, Switched From Oral To Sc Administration Due To Gastrointestinal Side Effects

dc.contributor.authorBorman, Pinar
dc.contributor.authorDemir, Gülseren
dc.contributor.authorKaygısız, Ferda
dc.contributor.authorOkumuş, Muyesser
dc.date.accessioned2019-12-10T10:53:21Z
dc.date.available2019-12-10T10:53:21Z
dc.date.issued2014
dc.identifier.urihttps://doi.org/10.2174/1874312901408010018
dc.identifier.urihttp://benthamopen.com/ABSTRACT/TORJ-8-18
dc.identifier.urihttp://hdl.handle.net/11655/14614
dc.language.isoen
dc.relation.isversionof10.2174/1874312901408010018
dc.rightsinfo:eu-repo/semantics/openAccess
dc.titleLetter To The Editor: Subcutaneous (Sc) Methotrexate (Mtx) Is Better And Well-Tolerable Than Oral Mtx In Rheumatoid Arthritis Patients, Switched From Oral To Sc Administration Due To Gastrointestinal Side Effects
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.relation.journalThe Open Rheumatology Journal
dc.contributor.departmentFiziksel Tıp ve Rehabilitasyon
dc.identifier.volume8
dc.identifier.issue1
dc.identifier.startpage18
dc.identifier.endpage19
dc.description.indexPubMed


Files in this item

Name:
licence.txt
Size:
265bytes
Format:
Text file
View/Open
Name:
Borman et al. - 2014 - LETTER ...
Size:
145.9Kb
Format:
PDF
View/Open

This item appears in the following Collection(s)

Show simple item record